Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00574704
What this trial is testing

Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Who this might be right for
Perennial Allergic RhinoconjunctivitisHouse Dust Mite Allergy
Cytos Biotechnology AG 40
Testing effectiveness (Phase 2)Study completedNCT00861744
What this trial is testing

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Who this might be right for
RubellaMumpsMeasles+1 more
GlaxoSmithKline 1,259
Large-scale testing (Phase 3)Study completedNCT01346293
What this trial is testing

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Sanofi Pasteur, a Sanofi Company 3,372
Early research (Phase 1)Study completedNCT00788164
What this trial is testing

Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical CancerPrecancerous ConditionHPV Disease+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 75
Testing effectiveness (Phase 2)Ended earlyNCT04382898
What this trial is testing

PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)

Who this might be right for
Prostate Cancer
BioNTech SE 75
Early research (Phase 1)Looking for participantsNCT06946225
What this trial is testing

ACTengine® IMA203 Combined With mRNA-4203

Who this might be right for
Cutaneous MelanomaSynovial Sarcoma
Immatics US, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00708084
What this trial is testing

Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

Who this might be right for
Rabies
Crucell Holland BV 48
Large-scale testing (Phase 3)Looking for participantsNCT07112144
What this trial is testing

Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

Who this might be right for
Prevent Whooping CoughPrevent DiphtheriaPrevent Tetanus
Changchun BCHT Biotechnology Co. 1,650
Testing effectiveness (Phase 2)Looking for participantsNCT06751901
What this trial is testing

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Testing effectiveness (Phase 2)Study completedNCT00084656
What this trial is testing

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Bristol-Myers Squibb 77
Early research (Phase 1)Study completedNCT03392389
What this trial is testing

Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults

Who this might be right for
Human Metapneumovirus and Human Parainfluenza Infection
ModernaTX, Inc. 124
Early research (Phase 1)Ended earlyNCT01312376
What this trial is testing

Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer

Who this might be right for
Ovarian CarcinomaFallopian Tube CancerPrimary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05557591
What this trial is testing

A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals 51
Large-scale testing (Phase 3)UnknownNCT00017290
What this trial is testing

Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Genitope Corporation
Large-scale testing (Phase 3)Study completedNCT00425360
What this trial is testing

Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Royal Liverpool University Hospital 1,110
Testing effectiveness (Phase 2)Study completedNCT02107391
What this trial is testing

Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
SOTIO a.s. 63
Large-scale testing (Phase 3)Study completedNCT01214889
What this trial is testing

Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi 370
Early research (Phase 1)Study completedNCT02431312
What this trial is testing

Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects

Who this might be right for
Hepatitis B
Inovio Pharmaceuticals 90
Testing effectiveness (Phase 2)WithdrawnNCT02452281
What this trial is testing

Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Rabih Said
Early research (Phase 1)UnknownNCT04072900
What this trial is testing

A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma

Who this might be right for
Melanoma (Skin)
Xiangya Hospital of Central South University 30
Next Page